In 2020 I founded NB Solutions to provide strategic advice around clinical research technology/data to a portfolio of small and mid-size clinical technology, CRO, HEOR and pharma/biotech companies, as well as a select set of PE companies whose focus is in the digital health space.  Working with Founders, Boards and CEOs NB Solutions acts as a trusted partner to companies looking to scale their business and reach their next investment milestone.  I also currently sit on the Board of Directors at IDDI (a specialist Biostatistics CRO). Successful engagements for NB Solutions have included:Ignite Data - leaders in agnostic interoperability between EHR and EDC who successfully closed seed funding of $8m.Algorics - a biostatistics CRO who were acquired by Precision for Medicine. MyMeds&Me - specialists in the capture of safety information who were acquired by Stanley Capital and now form part of Qinecsa.Cisiv - experts in collating and curating real world data who took funding to expand their platform.Due diligence on behalf of PE in for both eClinical and CRO transactions of UK, European and US companies.NB Solutions builds on my previous experience of delivering high quality strategic solutions to the pharmaceutical industry while working in first-in-class global clinical technology companies and Contract Research Organisations (CRO), as well as seven years in public health research departments of world leading academic organisations.  I subsequently took the knowledge gained while working for large established companies and applied in start-up, scale-up, and fast-growing ones.  Over a three year cycle jointly founded, built and sold a clinical technology company to a top 10 eClinical industry competitor. I've been a board member for small/mid size CRO and technology companies and chaired the board of a 2000 member industry body, and have stakeholder engagement and customer relationship management experience on the ground and remotely across many geographies including US, Europe, China, Japan, India.  Digital Health. Digital Innovation. Digital Transformation. Decentralised Trials. Smart Trials. Virtual Trials. Clinical Technology.  Board Experience. International Business Expansion. Business Growth.